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Abstract: Caffeine is the world’s most commonly used stimulant of the central nervous system.
Caffeine is present in coffee and other beverages such as tea, soft drinks, and cocoa-based foods.
The caffeine expectancy questionnaire was developed to investigate the effects of caffeine expectations
and thus contribute to knowledge about its usage and subjective effects (response expectancies).
This study aimed to evaluate caffeine expectation psychometrically in a sample of the Brazilian
population. The original version of the “Caffeine Expectancy Questionnaire (CaffEQ)” was translated
and validated into Brazilian-Portuguese and adapted to Brazilian culture to be used in the Brazilian
adult (19–59 y) population. After the translation and back-translation processes of the original
CaffEQ questionnaire, the content and semantic validation were performed by a group of experts.
The Brazilian-Portuguese version of the questionnaire consists of 47 items, in seven factors,
which assess subjective perceptions about the effects of caffeine. Interobserver reproducibility
and internal consistency of the questionnaire were tested with a convenience sample (n = 50) of
Brazilian adult consumers of caffeine sources, who completed the Brazilian CaffEQ (CaffEQ-BR)
on two occasions separated by 24 h. All of the 47 questions were adequate regarding reliability,
clarity, and comprehension. Psychometric properties could be replicated consistently. Appropriate
internal consistency and validation were confirmed by Cronbach’s alpha (α) 0.948, and an intraclass
correlation coefficient of 0.976 was observed. The CaffEQ-BR was applied using a web-based platform
to a convenience sample of Brazilian adults from all 27 Brazilian states (n = 4202 participants),
along with measures of sociodemographic and caffeine consumption data. Factor validity was
verified by confirmatory factor analysis. The seven factors presented a good fit for Root Mean Square
Error of Approximation—RMSEA = 0.0332 (95% CI: 0.0290–0.0375). By confirming the validity and
reliability of CaffEQ-BR, a useful tool is now available to assess caffeine expectations in the Brazilian
adult population.
Keywords: caffeine; subjective; expectancy; instrument; validation; Brazilian; Portuguese
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1. Introduction
Caffeine (1,3,7-trimethylxanthine) is the most widely consumed psychoactive substance in
the world [1,2] with several guidelines addressing the form of use, dosage, and limits for safe
consumption [3–5]. Worldwide, and in Brazil, caffeine intake occurs primarily through coffee
consumption [1]. The estimation of the Brazilian population’s average daily coffee intake is 163 mL [6],
being the most consumed non-alcoholic drink in Brazil [7,8]. In addition, caffeine is also widely
consumed in other foods and beverages such as cola, cocoa, chocolate, guarana, and in matte, black,
and green teas [9]. Furthermore, a range of energy drinks and sports supplements also contain caffeine
in their composition [5]. The differences in biological individuality and cultural factors can influence
the habits of caffeine consumption [10,11]. Therefore, the ingestion of products that contain caffeine is
not only associated with their sensorial characteristics and eating habits but also with caffeine effect
expectations [12].
It is well established that placebo effects are associated with caffeine supplementation, likely due
to an expectancy surrounding its effects. Double-blind studies have shown that participants receiving
a placebo treatment perceived to be caffeine improved exercise performance to a similar extent when
compared with caffeine ingestion [13,14]. Positive expectation associated with caffeine ingestion
appeared to drive this effect since individuals correctly believing that they had ingested caffeine
improved to a greater extent than the average effect of caffeine [13,15]. However, these results
were not observed in physiological variables, such as heart rate and blood pressure [16], further
reinforcing the notion that the expected effect of caffeine plays a subjective role in the belief around
its consumption [16,17]. Regarding expectancy, factors such as motivation and belief can influence
the ergogenic response of caffeine in adults [17]. Therefore, expectancies associated with caffeine
use/outcome may play an important role in the development, maintenance, and reinforcement of its
consumption patterns [12,18,19]. Studies have attempted to associate habitual caffeine consumption
with changes in mood, appetite, sleep/alertness, exercise performance, and other factors [19–21].
Based on these observations, standardized questionnaires were constructed using psychometric
techniques [22] to assess expectancy about caffeine consumption [19–21], or to evaluate the motives for
caffeine consumption [12].
In this regard, Heinz et al. (2009) [18] proposed a questionnaire with 37 items to examine
caffeine expectancy comprising four factors: ‘withdrawal symptoms’, ‘positive effects’, ‘acute negative
effects’, and ‘mood effects’. Subsequently, Huntley and Juliano (2012) [20] proposed the Caffeine
Expectancy Questionnaire (CaffEQ), a structured questionnaire based on a detailed review of the
literature and a series of preliminary studies for construction of the items. The final version of
the CaffEQ (originally in English, designed for the United States of America) includes 47 items,
evaluated using a six-point Likert scale, distributed across seven factors: ‘withdrawal/dependence’,
‘energy/work enhancement’, ‘appetite suppression’, ‘social/mood enhancement’, ‘physical performance
enhancement’, ‘anxiety/negative physical effects’ and ‘sleep disturbance’. Besides its use in the English
language, the CaffEQ was also translated and validated for German-speaking countries (Germany,
Switzerland, and Austria) by the authors Schott et al. (2016) [21].
However, since the validation and standardization of the CaffEQ questionnaire were performed
only for English and German speaking populations [19–21], there are currently no studies with Latin
American countries using the CaffEQ due to linguistic barriers and cultural differences that cause
difficulties in using the original questionnaire. In this sense, there has been no study proposed to
evaluate caffeine expectations in the Brazilian population due to the lack of a valid questionnaire in the
Brazilian-Portuguese language. Therefore, this study aimed to translate, culturally adapt, and validate
the CaffEQ to the Brazilian population (CaffEQ-BR), and also to evaluate caffeine expectations in
Brazilian adult participants. We expect that this study can provide a questionnaire with internal and
external validity to characterize caffeine expectations in the Brazilian adult population and be an easy
questionnaire to incorporate into research and clinical contexts.
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2. Materials and Methods
The present study used the original CaffEQ and translated it from the English version to
Brazilian-Portuguese [20]. The CaffEQ is composed of 47 items, evaluated using a six-point Likert scale.
In order to create the CaffEQ for the Brazilian population (CaffEQ-BR), our study was conducted in four
stages: (1) Translation, Cultural Adaptation, and Semantic Evaluation; (2) Internal Consistency and
Reproducibility of CaffEQ-BR; (3) Brazilian nationwide CaffEQ-BR application; (4) Statistical analysis.
The study was approved by the Ethics Committee of the University Católica of Brasília (Brasília, Brazil)
(number: 23019319.3.0000.0029) and followed the guidelines established by the Declaration of Helsinki.
The volunteers were informed about the study protocol and provided web-based consent.
In the present study, the survey was carried out using Google Forms™ web-based platform [23].
The online form maintained the original CaffEQ version layout and content [20]. The expert panel
suggested inserting an explanation about the meaning of the word caffeine (as well as about its main
sources) in the questionnaire heading for a better understanding of the questionnaire by the general
public, since the term “caffeine” is not common to the Brazilian population.
2.1. Translation, Cultural Adaptation, and Semantic Assessment
The translation and cultural adaptation of the questionnaire was performed according to World
Health Organization (WHO) recommendations [24]. A bilingual researcher native in Portuguese
(T.H.M.d.C.) translated the original version (in English) of the CaffEQ into the Brazilian-Portuguese
language. Subsequently, another bilingual researcher, a native English speaker (resident in Brazil for
eight years) (B.S.), with no knowledge of the original work, back-translated the Brazilian-Portuguese
version (made by T.H.M.d.C.) into English. After that, three collaborators (G.F.M.; C.E.G.R.; R.P.Z.)
compared the back-translated version (in English, made by B.S.) with the original questionnaire and
analyzed the Brazilian-Portuguese translation version to make adjustments in case of non-conformities.
The final version was agreed upon by the bilingual translators (T.H.M.d.C. and B.S.) as a final step in
the translation process.
The questionnaire was subsequently analyzed and revised by a panel of health professional experts
(n = 20) distributed across the following academic degrees: Master’s (n = 7; 35%), Doctorate (n = 9; 45%)
and Post-doctorate (n = 4; 20%), all associated with universities and all residents in Brasília Federal
District [22]. The experts individually analyzed the cultural adaptation and semantic assessment
using parameters of the ‘importance’ and ‘clarity’ of each question (n = 47) on a Likert scale of 1 to 5,
where 1 indicates “I totally disagree with the item”; 2—“I partially disagree with the item”; 3—“I
neither agree nor disagree with the item”; 4—“I partially agree with the item”; and 5—“I fully agree
with the item”. The objective was to achieve more than 80% agreement among the experts (mean > 3)
for each question [25,26]. Pending items were adjusted according to the experts’ observations and
sent back to them for compliance analysis. This process occurred until all items achieved at least 80%
agreement (mean > 3). The degree of agreement among experts in the evaluation of the ‘importance’ and
‘clarity’ of the questions was performed by the Kendall correlation coefficient (W) ranging from 0 to 1.
A W-value ≥ 0.66 indicates that the experts applied the same evaluation standards, and W-values < 0.66
suggest disagreement between experts. To approve an item, it was deemed necessary that at least 80%
agreement was achieved among the experts (W values ≥ 0.8) [26].
2.2. Internal Consistency and Reproducibility of CaffEQ-BR
The reproducibility of the translated and adapted instrument CaffEQ-BR was analyzed before
nationwide application since, before application in a large sample, it is important to test the
reproducibility (reliability) and internal consistency with a small sample size [27]. Internal consistency
refers to the variation in measurements made under changing conditions and reproducibility evaluates
the agreement between any two measurements made on the same subject [27].
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For this purpose, the questionnaire was applied using the Google Forms™ platform to a
convenience sample (n = 50) of Brazilian adults (>19–59 y) who were regular consumers of caffeine
from various sources. Participants were invited through pilot advertising on social media (for example,
Facebook™, Instagram™, and WhatsApp™). The questionnaire was answered twice (test-retest) by
each person. The second questionnaire was sent within 24 h and returned within the next 24 h.
The test-retest questionnaires evaluated reproducibility. It is important to note that the participants did
not previously know that they would have to answer the questionnaire a second time. The test-retest
reliability (reproducibility) analysis was performed using the intraclass correlation coefficient (ICC),
and the internal consistency of the factors was verified using Cronbach’s alpha (α). The number of
individuals used in this step was considered sufficient once the results were statistically significant
(p < 0.05) and the effect size was significant (alpha > 0.9 and ICC > 0.6) [28,29].
2.3. Brazilian Nationwide Application of CaffEQ-BR
In order to validate the CaffEQ-BR in Brazil and also to evaluate the Brazilian adult population,
we used a questionnaire composed of three parts: (i) sociodemographic and health-related questions;
(ii) evaluation of caffeine consumption; and (iii) the CaffEQ-BR. According to Hair et al. (2010) [30],
the process of validating a questionnaire requires 20 respondents per item (20:1). In this sense,
the minimum sample size was estimated as 940 participants to validate this questionnaire composed
of 47 items. In addition, as this is a nationally external validation study, the sample size adopted for
calculation was in accordance with the last Brazilian national census [26], with adequacy greater than
or equal to 70% of the sample distribution, according to the various states of Brazil. In the example
of the state of Rio de Janeiro, the population of 17,264,943, represents 8.22% of the population of
Brazil. Therefore, the CaffEQ-BR sample, to obtain 100% adequacy, must have 8.22% of its total sample
composed of participants from the state of Rio de Janeiro. In this way, we balanced the sample among
the states of Brazil.
The questionnaire was applied using the Google Forms™ platform to a convenience sample
of Brazilian adults from all 27 Brazilian states. Participants were recruited by advertising on social
media (e.g., Facebook™, Instagram™, and WhatsApp™) [21]. The data collection period occurred
from December 2019 to April 2020.
The initial page of the online survey presented the informed consent form with details of the
inclusion criteria: (i) adults (>19–59 y) [31,32]) living in Brazil; (ii) regular consumer of caffeine
sources (at least three times per week [33]), later confirmed by the caffeine consumption questionnaire.
Those who did not agree to participate were directed to a page thanking them for their time,
while those who agreed were directed to the first page of the questionnaire with sociodemographic
and health-related questions, then caffeine consumption assessment and the 47-item CaffEQ-BR.
2.3.1. Sociodemographic and Health Data
Sociodemographic variables were gender; self-identification of ethnicity; state of the federation
of current residence; education level; and average monthly income (BRL/month/person or family).
The variables concerning health aspects were height (m) and weight (kg) (self-reported);≥150 min weekly
physical exercise; and previous diagnosis of self-reported chronic diseases with current medication.
2.3.2. Caffeine Consumption
The caffeine consumption questionnaire [33,34] was used to assess the caffeine consumed over the
past two weeks prior to the completion of the questionnaire. Participants were asked to indicate the
number of servings of coffee, tea, soft drinks, energy drinks, and other caffeine-containing products
consumed. The questionnaire also includes a list categorized into eight groups of caffeine sources:
1. Filtered or espresso, hot or iced coffee; 2. Tea sources of caffeine like mate, green and black tea;
3. Pure chocolate with 50% cocoa; 4. Chocolate beverages with 50% cocoa; 5. Cola or guarana based
soft drinks; 6. Caffeinated drugs; 7. Commercial drink sources of anhydrous caffeine or guarana
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extract beverage; 8. Sports supplements sources of anhydrous caffeine. Standardized doses of coffee,
in homemade measures, were adopted according to the national reference study [35]. The typical
serving size and caffeine values were based on the products’ manufacturer information and the food
composition table [36].
2.4. Statistical Analysis
A confirmatory factor analysis verified the factor validity. The factor validity was evaluated by
the Root Mean Square Error of Approximation (RMSEA). The RMSEA ranges from 0 to 1, where the
value 0 indicates a perfect model fit. A value of 0.05 or less is indicative of an acceptable model fit.
Caffeine intake was expressed as a mean ± standard deviation (SD). Shapiro-Wilk test was used to
evaluate the normality of distribution. The independent samples t-test was used to compare means
between gender. All tests were conducted considering a significance level of 5%. The statistical
packages IBM SPSS (Statistical Package for Social Sciences) version 22 (IBM SPSS Statistics for Windows,
IBM Corp, Armonk, NY, USA) and IBM SPSS AMOS (Analysis of Moment Structures) version 22
(Amos, IBM SPSS, Chicago, IL, USA) were used for the analyses.
3. Results
3.1. Translation, Cultural Adaptation, Semantic Evaluation, and Content Validation
The CaffEQ-BR (available in Brazilian-Portuguese in Appendix A) was constructed considering
the translation/back-translation process and the suggestions made by the expert panel. Following the
translation/back-translation phase, the first stage of semantic evaluation and content validation was
carried out by the panel of 20 experts who decided to keep 47 items with cultural and semantic
adaptations, since we chose to follow the original CaffEQ questionnaire [20]. Throughout three rounds
of assessment, with modifications in the items regarding cultural and semantic aspects, the experts
reached agreement (≥80%) on the evaluation of the 47 items in the questionnaire. After that, with a
convenience sample of 50 Brazilian adults (60% female, 36.4 ± 12.4 y, 62.2% self-identification as white),
the internal consistency and reproducibility of CaffEQ-BR were verified. A summary of the translation,
cultural adaptation, semantic evaluation, and content validation processes for CaffEQ-BR is shown
in Figure 1.
3.2. Reproducibility and Internal Consistency of the CaffEQ-BR
All seven factors of the CaffEQ-BR showed no significant difference (ICC > 0.9) in the responses
from the same individual (n = 50) (Table 1). As shown in Table 1, all seven factors indicated good
internal consistency (α ≥ 0.8) [29,37].
Table 1. Reproducibility and internal consistency of the instrument and factors of the Caffeine








Withdrawal/dependence 12 0.948 (0.923–0.968) 0.983 (0.969–0.991)
Energy/work enhancement 8 0.926 (0.888–0.923) 0.953 (0.912–0.975)
Appetite suppression 5 0.872 (0.802–0.923) 0.951 (0.903–0.974)
Social/mood enhancement 6 0.889 (0.829–0.932) 0.949 (0.900–0.973)
Physical performance enhancement 3 0.924 (0.875–0.956) 0.965 (0.936–0.981)
Anxiety/negative physical effects 9 0.872 (0.807–0.921) 0.953 (0.907–0.976)
Sleep disturbance 4 0.941 (0.907–0.965) 0.970 (0.945–0.983)
Overall 47 0.948 (0.923–0.967) 0.976 (0.935–0.989)
* For reproducibility and internal consistency of items and factors of the CaffEQ-BR, conducted with a convenience
sample of 50 Brazilian adults: 60% female, 36.4 ± 12.4 y, 62.2% of self- identification as white.
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Figure 1. Flowchart of translation, cultural adaptation, semantic evaluation, content validation
processes and application of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR).
3.3. Brazilian Nationwide Application of the CaffEQ-BR
3.3.1. Participants
From 4339 individuals who responded to the online CaffEQ-BR questionnaire, the final sample
was composed of 4202 participants, since some participants (n = 137) did not provide all the data
necessary for their inclusion in the survey. The nationwide distribution of the participants among
the Brazilian states is presented in Figure 2. Participants were mostly from the Southeast Brazilian
region (n = 1390; 33.08%), followed by the Northeast (n = 1175; 27.96%), Midwest (n = 716; 17.04%),
South (n = 566; 13.47%) and North (n = 355; 8.45%). The state with the highest participation was
São Paulo-Southeast region (n = 683; 16.25%), and the lowest was Acre-North region (n = 18; 0.43%).
Figure 2 shows the methodological rigor of adequacy of 70% or more in the sample representation,
according to the last national census [38], since all Brazilian states achieved this goal. Figure 2 also
displays the mean of participants’ caffeine and coffee consumption by each Brazilian state.
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frequent educational level (n = 2477; 59%). A monthly income between 3000.01 and 5000.00 (BRL)
was the most frequent (n = 865; 20.6%). A large part of the sample did not report having any chronic
disease (n = 3397; 80.8%). More information on sociodemographic aspects is shown in Table 2.
Table 2. Sociodemographic data, sample profile of the CaffEQ-BR study (2019–2020).
Categories





















Without description 80 1.9
Physical Exercises ≥ 150 min/week No 1924 45.8
Yes 2278 54.2
Educational Level
No schooling 3 0.1
Incomplete elementary school 17 0.4
Completed elementary school 37 0.9
Incomplete high school 101 2.4
Completed high school 596 14.2
Incomplete higher education 955 22.7
Higher education graduate 1162 27.6
Postgraduate studies 1315 31.3
Without description 16 0.4
Monthly Income (BRL) **
1000.00 407 9.7
1000.01 to 2000.00 769 18.3
2000.01 to 3000.00 669 15.9
3000.01 to 5000.00 865 20.6
5000.01 to 10,000.00 796 18.9
Above 10,000.00 575 13.7
Without description 121 2.9
Self-Reported Chronic Diseases No 3397 80.8
Yes 805 19.2
* Body mass index (BMI) followed the criteria adopted by the World Health Organization (WHO) [39] underweight
(BMI < 18.5 kg/m2), adequate (BMI between 18.5 and 24.9 kg/m2), overweight (BMI between 25 and 29.9 kg/m2) and
obesity (BMI ≥ 30 kg/m2). ** 5.55 BRL = 1.00 USD on the last day of data collection, April 2020.
3.3.2. Caffeine Consumption
Based on weekly consumption of caffeine sources, the average daily intake observed was
265± 159 mg (minimum 49 mg; maximum 1200 mg). The total caffeine intake for males (274± 162 mg/day)
and for females (256 ± 155 mg/day) was statistically different (t = 3703; df = 4200; p < 0.001). Figure 2
shows descriptive data of average caffeine consumption by Brazilian states. A very similar pattern
of consumption was observed between states. The average consumption by regions was as follows:
North (n = 355; caffeine consumption: 253 ± 150 mg/day); Northeast (n = 1175; caffeine consumption:
262 ± 157 mg/day); Midwest (n = 716; caffeine consumption: 267 ± 162 mg/day); Southeast (n = 1390;
caffeine consumption: 267 ± 158 mg/day); South (n = 566; caffeine consumption: 274 ± 164 mg/day).
Thus, the highest absolute consumption of caffeine was in the southern region. Table 3 shows the
distribution of consumption of caffeine sources and the time of the day that these were consumed.
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Table 3. Distribution frequency of regular consumption of sources of caffeine per week (n = 4202).
Caffeine Sources 1 Coffee 2 Tea 3 Chocolate 4
Chocolate
Beverages 5 Soft Drinks
6 Medication 7 EnergyDrinks 8
Sports
Supplements 9
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Time of the Day
Early morning (00:00–06:00) 202 4.8% 79 1.9% 153 3.6% 70 1.7% 149 3.5% 115 2.7% 109 2.6% 19 0.5%
Morning (06:00–12:00) 3853 91.7% 503 12.0% 644 15.3% 653 15.5% 362 8.6% 505 12.0% 188 4.5% 333 7.9%
Afternoon (12:00–18:00) 2829 67.3% 686 16.3% 1594 37.9% 523 12.4% 1361 32.4% 396 9.4% 324 7.7% 206 4.9%
Evening (18:00–24:00) 1508 35.9% 878 20.9% 1291 30.7% 563 13.4% 1058 25.2% 699 16.6% 348 8.3% 122 2.9%
N◦ of Servings
Per Day
1 971 23.1% 1178 28.0% 1647 39.2% 908 21.6% 985 23.4% 824 19.6% 530 12.6% 463 11.0%
2 1958 46.6% 322 7.7% 537 12.8% 273 6.5% 543 12.9% 209 5.0% 141 3.4% 78 1.9%
3 983 23.4% 92 2.2% 235 5.6% 89 2.1% 209 5.0% 111 2.6% 43 1.0% 19 0.5%
4 139 3.3% 12 0.3% 64 1.5% 22 0.5% 58 1.4% 35 0.8% 7 0.2% 1 0.0%
Total Recorded 4051 96.4% 1604 38.2% 2483 59.1% 1292 30.7% 1795 42.7% 1179 28.1% 721 17.2% 561 13.4%
1 Standardization of the portions in the consumption frequency table was adopted based on the dose of 50 mg of caffeine/portion. The percentages exceed 100% because consumption
can occur in two or more periods. 2 Filtered or espresso, hot or iced coffee. 3 Tea sources of caffeine like mate, green and black tea. 4 Pure chocolate with ≥ 50% cocoa. 5 Chocolate
beverages with ≥ 50% cocoa. 6 Cola nut or guarana based soft drinks. 7 Caffeinated medications. 8 Commercial drink sources of anhydrous caffeine or guarana extract beverage. 9 Sports
supplements sources of anhydrous caffeine.
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The participants’ main source of caffeine was coffee, mostly consumed in the morning. In the
afternoon, soft drinks and chocolates were the primary sources of caffeine. In the evening,
the consumption of coffee, teas, chocolate, soft drinks, caffeine medications, and energy drinks
was more frequent. Chocolate beverages showed no difference in consumption during the day.
Caffeine-based sports supplements were most frequent in the morning. Coffee was the only source of
caffeine with a predominance (73.3%) of consumption of two or more servings daily.
3.3.3. Confirmatory Factor Analysis and Associations of the CaffEQ-BR
Based on the national sample (n = 4202), the external factor validity of CaffEQ-BR was verified by
confirmatory factor analysis. The seven factors presented RMSEA = 0.0332 (95% CI: 0.0290–0.0375),
which shows satisfactory external validity.
Table 4 shows the results of the Pearson correlation coefficient between the CaffEQ-BR scores,
divided between the seven factors, and the consumption of caffeine. All correlation between caffeine
consumption and CaffEQ-BR factors (F1 to F6) were positive weak (r < 0.4) and significant (p < 0.001),
except for F7 (−0.074; p < 0.001). Therefore, the higher the consumption, the higher the score. Despite the
weak correlation (r < 0.4), the association between caffeine consumption and the CaffEQ-BR scores
were all significant (p < 0.001), due to the large sample size (n = 4202).
Table 4. Correlations Between Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) Factors and
Caffeine-Related Variables (n = 4202).
Sources
Factors of the CaffEQ-BR *
F1 F2 F3 F4 F5 F6 F7
Caffeine ** (mg/day) 0.085 *** 0.102 *** 0.081 *** 0.141 *** 0.097 *** 0.095 *** −0.074 ***
* Factors of the CaffEQ-BR: F1 Withdrawal/dependence; F2 Energy/work enhancement; F3 Appetite suppression;
F4 Social/mood enhancement; F5 Physical performance enhancement; F6 Anxiety/negative physical effects; F7 Sleep
disturbance; ** Caffeine in general sources (Tea, coffee, chocolate above 50% cocoa, chocolate beverages, cola nut or
guarana based soft drinks, caffeinated drugs, commercial drinks and sports supplements sources of anhydrous
caffeine or guarana extract beverage); Pearson correlation *** p < 0.001.
In Table 5, the region of Brazil with the highest average for F1 factor (withdrawal/dependence)
was the southeast. The F2 (energy/work) enhancement factor resulted in the highest average score
among all factors and was similar between regions in Brazil. The F3 factor (appetite suppression) was
below 3 on the six-point Likert scale for all regions of Brazil. The factors F4 (social/mood enhancement)
and F5 (physical performance enhancement) were above 3 on the Likert scale, with emphasis on the
upper average for F4 in the north region, and the lower average for F5 in the south region of Brazil.
The F6 factor (anxiety/negative physical effects) resulted in the lowest average score among all factors,
with a similarity between regions. The F7 factor (sleep disturbance) was also below 3 on the Likert
scale, with the lowest average for the south region of Brazil.
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Table 5. Mean and Standard Deviation (SD) of the scores on a six-point Likert scale of the seven factors
of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) by regions of Brazil (n = 4202).
Regions **
Factors of the CaffEQ-BR * Mean (SD)
F1 F2 F3 F4 F5 F6 F7
North 3.48 (1.49) 4.16 (1.37) 2.21 (1.15) 3.56 (1.45) 3.49 (1.55) 1.78 (0.69) 2.51 (1.60)
Northeast 3.44 (1.41) 4.15 (1.31) 2.24 (1.14) 3.44 (1.38) 3.55 (1.53) 1.81 (0.77) 2.45 (1.58)
Midwest 3.34 (1.39) 4.08 (1.32) 2.13 (1.14) 3.25 (1.34) 3.50 (1.53) 1.85 (0.82) 2.62 (1.69)
Southeast 3.60 (1.45) 4.17 (1.33) 2.26 (1.18) 3.41 (1.38) 3.47 (1.49) 1.75 (0.75) 2.44 (1.62)
South 3.47 (1.43) 4.08 (1.30) 2.36 (1.24) 3.42 (1.34) 3.24 (1.48) 1.74 (0.75) 2.36 (1.57)
Brazil 3.48 (1.43) 4.14 (1.32) 2.24 (1.17) 3.41 (1.38) 3.47 (1.51) 1.78 (0.77) 2.47 (1.62)
* Factors of the CaffEQ-BR, range: 1.00–6.00: F1 Withdrawal/dependence; F2 Energy/work enhancement; F3 Appetite
suppression; F4 Social/mood enhancement; F5 Physical performance enhancement; F6 Anxiety/negative physical
effects; F7 Sleep disturbance. ** Regions of Brazil: North Region-Acre, Amazonas, Amapá, Pará, Rondônia,
Roraima, Tocantins; Northeast Region-Alagoas, Bahia, Ceará, Maranhão, Paraíba, Pernambuco, Piauí, Rio Grande
do Norte, Sergipe; Midwest Region-Distrito Federal, Goiás, Mato Grosso, Mato Grosso do Sul; South Region-Paraná,
Santa Catarina, Rio Grande do Sul; Southeast Region-Espírito Santo, Minas Gerais, Rio de Janeiro, São Paulo.
4. Discussion
In this original study, we developed and validated the Brazilian version of the CaffEQ. Until now,
there has been no adaptation of CaffEQ to Brazilian-Portuguese in the cultural context of Brazil, or in
Latin American countries. Its application may assist in observational studies for clinical trials that
assess caffeine consumption in Brazil. The selected questionnaire also allowed us to make comparisons
with data available from other countries that used the same questionnaire [19–21]. The CaffEQ-BR is a
questionnaire designed to identify the expectations that Brazilian individuals have about the subjective
effects of caffeine on the biopsychosocial aspects involved in its consumption [19–21].
In order to create the CaffEQ-BR, the translation and back-translation process (linguistic validation
of the instrument) was necessary, since the original questionnaire was developed in another language
and there was no translated and validated version in the target language [24]. Therefore, the first
step of this study was to translate/retranslate the original version of CaffEQ from English to
Brazilian-Portuguese to English following the scientific guidelines proposed by the WHO [12,24].
After this, the questionnaire was sent to experts for evaluation, since semantic evaluation is necessary to
ensure its clarity and comprehension [40,41]. In this sense, CaffEQ-BR presented cultural and semantic
adequacy according to the consensus of the experts (at least 80% of agreement). After this stage, the
test-retest with 50 individuals was used to assess the reliability of the CaffEQ-BR, which analyzes the
questionnaire’s ability to reproduce consistent results [29,41]. The internal consistency of CaffEQ-BR
was measured by Cronbach’s alpha coefficient (α = 0.94), considered acceptable when ≥0.8 [28,37].
This result was similar to the findings of Huntley and Juliano (2012) [20] (n = 1046; α = 0.96), and
Schott et al. [21] (n = 352; α = 0.98) for the same questionnaire in English and German, respectively.
In addition, the CaffEQ-BR presented excellent measures of reproducibility (ICC = 0.97). This result
confirms that the questionnaire is able to consistently measure the subjective effects of caffeine perceived
by the interviewed user. Every scale used to measure health results needs this reliability performed by
exploratory and confirmatory factor analysis [37].
After internal validation of the CaffEQ-BR, we conducted a national study in Brazil, using a
sample of all 27 Brazilian states (Figure 2) with uniform distribution of age and sex (Table 2), similar to
the last available national census (Brazil-IBGE (Instituto Brasileiro de Geografia e Estatística) 2010) [42].
The national census is usually held every decade, and the 2020 edition is in progress. The first five
most populous Brazilian states (Figure 2) had two or more rounds of dissemination of the survey on
social networks, to achieve the established interview number goal. The Federal District had the highest
representation in percentage points because the research group is based in Brasília, Federal District.
Naturally, in a convenience sample, there was greater participation in our hometown.
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The sociodemographic data of the CaffEQ-BR participants are closer to the measures of the adult
Brazilian population on gender and age than the sample of the original study (CaffEQ) [20], which had
a predominance of young female students. Although the CaffEQ-BR sample is representative of the
population distribution parameters in the Brazilian states [38], there is a selection bias in relation to the
respondents’ education and socioeconomic level, which was above the national average family income
(1439 BRL per month in 2019) [43] directly influencing educational status [44]. Another factor was
the use of social networks to disseminate the research questionnaire. Other nationwide surveys in
Brazil from our institution/research groups, released through web-base, also observed greater access
by higher economic classes compared to the national average [45,46]. Therefore, it is not possible to
extrapolate our results to the entire Brazilian adult population. This is not a national census or national
sample representation.
Regarding the self-reported categories for BMI ≥ 25 and chronic disease being treated, our sample
data showed a lower incidence of these two variables (55.8%; 19.2%, respectively) compared to the
results of the Brazilian national study “Surveillance of risk and protective factors for chronic diseases
by telephone research” (VIGITEL 2019) (75.7%; 31.9%, respectively). However, our sample showed
a higher frequency of people who self-reported being physically active: 54.2%, compared to the last
VIGITEL (2019) which showed 39.5% [47]. The VIGITEL study used a representative random sample
only from the state capitals of Brazil, through phone interviews. Our survey did not cover capitals
only, with a convenience sample by invitation on social networks with predominant access via mobiles.
There was an inclination towards greater sample composition of middle-aged adults, with a higher
level of education and income for the CaffEQ-BR. There are studies that indicate a greater preference,
especially for coffee, in individuals with this sociodemographic profile [6–8]. The VIGITEL study in
different periods of time (2006 to 2019) showed that that part of the population that has more years of
schooling (≥12 years) is less overweight, sedentary, and chronically ill. The reverse context, low income
and education level and high morbidity rate, are also observed [48]. The self-reported ethnicity
comparison between the National Household Sample Survey (2018/2019) [43] and that obtained in
the CaffEQ-BR was: 45.2–55.4% of Brazilians that declared themselves as white, 45.0–31.6% as pardo,
8.8–8% as black, 0.47–2.7% as Asian descendants and 0.38–1.0% as indigenous.
The average caffeine intake in our sample (265 ± 159 mg/day) is above the published standards
for Brazil (115 ± 96 mg/day) [49]. According to Sartori et al., the survey on caffeine consumption
in Brazil was based on food sources, extracted from data from the national survey of 2008 and
2009 [49]. In addition to the difference in the observation periods (2008/09 vs. 2019/20), our survey
included other sources of caffeine as supplements and medications. This fact is relevant according to
Arrais et al. (2016) [50], as self-medication is a recurrent practice in Brazil, including among young
adults, mainly associated with the use of non-prescription medications, such as analgesics and muscle
relaxants. In the national market, these drugs take in their composition, on average, 30 to 50 mg of
caffeine per serving. Our study also focused on individuals who are regular consumers of caffeine
(from different sources); therefore, we expect that the participants’ average usual intake could be higher
than the general Brazilian population. These values were similar to those found by Schott et al. (from
Germany, Switzerland, and Austria: 236 ± 235 mg/day) [21] but considerably below the consumption
found by Huntley and Juliano (from U.S.: 323 ± 297 mg/day), which was based on the consumption of
a younger population, containing many college/university students [20]. Another point is that the
volume of coffee consumed in Brazil is not a standard variable to be compared with a North American
or European study, since Brazilians and inhabitants of other Latin American countries usually drink
small portions of stronger coffee (approx. 50 mL of small cups) compared to the American culture
of large cups (approx. 250 mL) of lighter coffee, a fact observed by De Paula and Farah (2019) [51].
Total caffeine intake in males (274 ± 162 mg/day) was higher than in females (256 ± 155 mg/day),
similar to the results observed by other studies [8,49,52]. Probably these gender differences are
related to cultural and behavioral factors in males as well as to the gender differences in physiological
responses to caffeine [53–56]. A study showed that males differ in cardiovascular responses to caffeine,
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while females did not differ in their responses as a function of typical caffeine use [55]. Males also
presented greater decreases in heart rate in response to caffeine than did females, probably related
to changes in circulating steroid hormone, in which increased circulating estradiol increases the
physiological and subjective effects associated with caffeine, influencing the high consumption of
caffeine on males [53].
Across previous CaffEQ studies, caffeine was consumed mainly in coffee, a habit also observed
in Brazil [6–8]. Globally, habitual coffee consumption ranges from about 1 to more than 5 cups per
day, which indicates that the daily dose is defined by several reasons, like lifestyle, gender, expectance
of caffeine effects, culture, genetics, health effects, among others [2,36,57]. Most of our sample (69%)
are used to consuming 2 or 3 portions of coffee daily (Table 3). The culture of coffee in Brazil has a
historical origin in its production capacity, as it is the largest coffee exporter in the world market [58].
Brazil accounts for one-third of the world’s coffee production, making it the world’s largest producer,
a position it has occupied for more than 150 years. In Brazil, at the beginning of the 19th century, coffee
was already treated as an investment. With the expansion of plantations in the country, there was also
an expansion of investment favoring urbanization, such as the construction of railroads responsible
for the national distribution and export of coffee, in addition to the arrival of immigrants. Thus,
in Brazil, coffee is considered one of those products responsible for the modernization, urbanization
and development of some cities [59], and it is still widely consumed and appreciated throughout
the country. Annual per capita Brazilian consumption is 6.02 kg, which represents 13% of world
demand [60]. Easy access to coffee naturally influences the consumption culture of Brazilians [8].
Coffee is the main drink consumed, with an average of 163 mL per day, and is also the second most
consumed food [6,7].
In Brazil, coffee consumption is widespread [6]. This reflects a very similar average consumption
between regions [6], as observed in the CaffEQ-BR survey. The differences are greater when other
eating habits are associated with the daily use of coffee. For example, the habit of consuming a hot mate
called “Chimarrão” in the south region, a cold mate called “Terere” in the Midwest region [61] and
guarana extract in the northern region of Brazil [62]. The fact that the Northeast region is the largest
consumer of coffee was also confirmed by the study of Sousa and Da Costa [6]. We also emphasize that
coffee and other caffeine sources are also sources of other bioactive compounds, including polyphenols
and chlorogenic acids [63]. However, the main substance with psychoactive properties is caffeine,
confirmed by several meta-analyses [4]. The construction of the original CaffEQ [20] takes into account
the estimated average consumption of caffeine in general (from all sources), without the intention of
associating it with other compounds present in food sources of caffeine.
The statistical correlations (r < 0.4) shown between CaffEQ factors, scores and caffeine consumption
were also observed in previous studies that used the original CaffEQ in the United States [20] and the
translated and validated version in German-speaking countries [21].
When observing the descriptive results of the CaffEQ-BR scores divided into seven factors using
the original questionnaire [20], it is possible to observe similarity in the factors Withdrawal/dependence
3.48 (1.43)–3.22 (1.45), Energy/work enhancement 4.14 (1.32)–3.92 (1.17), Appetite suppression
2.24 (1.17)–2.70 (1.20), Social/mood enhancement 3.41 (1.38)–2.98 (1.21), respectively. However,
there was a difference of approximately one point for the factors Physical performance enhancement
3.47 (1.51)–2.41 (1.07), Anxiety/negative physical effects 1.78 (0.77)–2.68 (1.04) and Sleep disturbance
2.47 (1.62)–3.20 (1.45). Differences in mean scores in the seven factors were also observed in the other
cultures where CaffEQ was studied [20,21].
Data from the latest survey published by the Brazilian Institute of Geography and Statistics
showed that three out of four Brazilians in metropolitan capitals (Belém (Pará), Fortaleza (Ceará),
Recife (Pernambuco), Salvador (Bahia), Belo Horizonte (Minas Gerais), Rio (Rio de Janeiro), São Paulo
(São Paulo), Curitiba (Paraná) and Porto Alegre (Rio Grande do Sul)) have access to the Internet,
and the number of households with landlines dropped from 33.6 % to 31.5%, while ownership of
devices with mobile internet increased from 92.6% to 93.2% [64]. The smartphone was also the main
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tool used to access the internet. Therefore, although web-based research may be limited because it is
not possible to reach every portion of the population, it can still be considered a viable strategy since
our web search could be answered on any device with internet. There is also the limitation of memory
and intake bias, which is intrinsically related to frequency questionnaires [65].
There is no other scientifically validated Brazilian research questionnaire that evaluates
consumption related to caffeine. Therefore, there are no parameters for comparison except with
the original version of the CaffEQ [20] and the German version [21]. Another important factor is
the heterogeneity of the Brazilian-Portuguese language in the national territory. Certainly, there are
aspects of regionality, but despite these limitations, due to the construction process in several stages
and the wide statistical confirmation, the Brazilian version of CaffEQ represents a reliable and valid
questionnaire to assess expectations of caffeine intake. Analytical item analysis confirms the quality of
the translated items. Overall, the CaffEQ’s translation and validation for Portuguese and Brazilian
culture were successful.
5. Conclusions
The full version of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR) is available for
Brazilian adults, translated into Portuguese and adapted to Brazilian culture. This study confirmed
the validity and reliability of the CaffEQ-BR. Its internal and external consistency allows its use
throughout the national territory, if the sampling conditions are similar. The CaffEQ-BR observed the
pattern of consumption of caffeine sources by Brazilian adults, confirming the national preference for
coffee as the main source of daily caffeine. Future studies may validate the CaffEQ-BR in children,
adolescents and the elderly, since caffeine is widely consumed across the lifespan. The present study
contributes to a better understanding of the expectations of the most used psychoactive substance in
Brazil, systematizing several expectations in seven factors that can be explored and categorized. Thus,
the CaffEQ-BR can be used to facilitate our understanding of the use of caffeine. Other studies may
also replicate our results, pointing out the temporal stability of the CaffEQ-BR, monitoring changes in
expectations in longitudinal exposure to caffeine.
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Appendix A
Questionário de Expectativa de efeitos da Cafeína/café, versão brasileira (CaffEQ-BR)
Instruções: Estamos interessados em suas crenças sobre os efeitos que a cafeína tem sobre você.
Abaixo há uma lista de possíveis efeitos da cafeína presentes nos produtos listados na tabela acima
preenchida. Usando a escala como guia, avalie cada afirmação em termos de quanto é PROVÁVEL
ou IMPROVÁVEL para esses efeitos como consequências do consumo da cafeína. As possibilidades
de respostas são: 1 = Muito improvável; 2 = Improvável; 3 = Um pouco improvável; 4 = Um pouco
provável; 5 = Provável; 6 = Muito provável. Baseie suas respostas no produto com cafeína que escolheu.
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Se você usa muitos tipos de produtos com cafeína, escolha o mais usual para basear suas respostas,












1. Cafeína/café me dá ânimo quando
estou cansado      
2. Eu fico extrovertido quando tomo
cafeína/café
     
3. Cafeína/café me ajuda a não comer
mais do que deveria
     
4. Fico facilmente estressado depois de
tomar cafeína/café
     
5. Cafeína/café melhora meu
desempenho físico
     
6. Fico menos cansado depois de
tomar cafeína
     
7. A cafeína/café tira minha fome      
8. Fico triste quando não tomo
cafeína/café
     
9. Cafeína/café melhora meu humor      
10. Eu fico ansioso quando não tomo
cafeína/café
     
11. Eu me sinto angustiado quando
tomo cafeína/café
     
12. Eu me exercito melhor depois de
tomar cafeína/café
     
13. Eu sinto muita falta de cafeína/café
quando não tomo
     
14. Eu não gosto do jeito que eu me
sinto após tomar cafeína/café
     
15. Eu me sinto mal se ficar sem
cafeína/café
     
16. Cafeína/café aumenta minha
motivação para trabalhar
     
17. Eu me sinto mais confiante depois
de tomar cafeína/café
     
18. Tomar cafeína/café a qualquer hora
do dia atrapalha o meu sono
     
19. Quando tomo cafeína/café fico
nervoso(a)
     
20. Quando tomo cafeína/café fico
mais alerta
     
21. Mesmo quando tomo uma pequena
quantidade de cafeína/café fico ansioso
     
22. Cafeína/café melhora minha
concentração
     
23. Quando tomo cafeína/café fico
mais amigável
     
24. Eu tenho que tomar cafeína/café
todos os dias
     
25. Cafeína/café me faz suar      
26. Cafeína/café me faz pular refeições      
27. Tenho muita vontade de tomar
cafeína/café se não tiver tomado a
quantidade de sempre
     
28. Tomar cafeína/café na hora de
dormir atrapalha meu sono
     
29. Cafeína/café me deixa irritado      
30. Eu desejo cafeína/café o tempo todo      












31. Cafeína/café me ajuda a trabalhar
por mais tempo
     
32. Cafeína/café me faz sentir feliz      
33. Eu não funciono sem tomar
cafeína/café
     
34. Quando tomo cafeína/café meu
coração acelera
     
35. Eu tenho dificuldade em começar o
dia sem tomar cafeína/café
     
36. Sinto dor de estômago quando
tomo cafeína/café      
37. Eu não conseguiria parar de tomar
cafeína/café
     
38. Tomar cafeína/café no final da
tarde atrapalha o meu sono
     
39. Cafeína/café me ajuda a regular
o peso
     
40. Quanto não tomo cafeína/café sinto
dor de cabeça
     
41. Cafeína/café melhora minha
atenção
     
42. Eu fico mais extrovertido(a)
quando tomo cafeína/café
     
43. Cafeína/café me ajuda a me
exercitar por mais tempo
     
44. Sinto-me mais disposto quando
tomo cafeína/café
     
45. Cafeína/café me faz sentir com
mais energia
     
46. Cafeína/café diminui o meu apetite      
47. Tomar cafeína/café no final do dia
não me deixa dormir
     
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